AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 22 filers reported holding AERPIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,193,946 | $6,492,000 | 0.09% |
| NEVILLE RODIE & SHAW INC | 100,000 | $125,000 | 0.01% |
| Bison Wealth, LLC | 16,500 | $21,000 | 0.01% |
| Tekla Capital Management LLC | 257,554 | $322,000 | 0.01% |
| JOHNSON INVESTMENT COUNSEL INC | 320,536 | $401,000 | 0.01% |
| Ascent Wealth Partners, LLC | 10,000 | $12,000 | 0.00% |
| Renaissance Technologies | 1,815,875 | $2,270,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 24,669 | $31,000 | 0.00% |
| Qube Research & Technologies Ltd | 33,442 | $42,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 15,204 | $19,000 | 0.00% |